PQ 85
85. Deputy Martin Daly asked the Minister for Health the reason the osteoporosis drug Prolia, denosumab, is not routinely available free of charge to men with confirmed debilitating osteoporosis in Ireland in the same manner as it is available to women in equivalent clinical circumstances; and the steps her Department is taking to ensure equitable access for male patients in the Roscommon–Galway constituency who could benefit from this treatment but currently face significant financial or access barriers. [64522/25]
Introduced
20 November 2025
Last action
—
Status
oral
Sponsors
—
Subjects
Discovery layer
Source updated
20 November 2025
Summary
85. Deputy Martin Daly asked the Minister for Health the reason the osteoporosis drug Prolia, denosumab, is not routinely available free of charge to men with confirmed debilitating osteoporosis in Ireland in the same manner as it is available to women in equivalent clinical circumstances; and the steps her Department is taking to ensure equitable access for male patients in the Roscommon–Galway constituency who could benefit from this treatment but currently face significant financial or access barriers. [64522/25]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 20 November 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2025-11-20/85/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2025-11-20/pq_85